Frankfurt-based financial investor Halder has acquired a majority stake in the family-run CPM Group, a medical technology manufacturer located in Hirschberg an der Bergstraße, Germany. Founder Claus-Peter Maier is selling his shares and exiting the company, while Halder plans to continue operating CPM with its current successful management team.
Founded in 2000, CPM Group comprises CPM Precision GmbH, CPM Deltaturn GmbH, and Nanolize GmbH. CPM has emerged as a leading supplier of medical implants, particularly strong in the dental sector. Beyond dental technology, CPM is active in orthopaedics and ophthalmic surgery, specializing in the contract manufacturing of medical turned, milled, and 3D printed components. The company manages the entire value chain from development and consulting to manufacturing, surface treatment, and sterilized packaging, ensuring high product quality through validated processes in medical technology.
With approximately 30 years of experience, Halder operates as an equity investor with six launched funds. The firm supports its investments in expansion and internationalization, advising on strategy, business models, capacity expansion, and financing of strategic acquisitions.
Specifics of the transaction between Halder and CPM Group have not been disclosed.
ConAlliance acted as the exclusive sell-side M&A advisor to CPM Group and its shareholders for this transaction.
With over 150 successful transactions, ConAlliance is a leading M&A advisory firm specializing in comprehensive support for company sales and acquisitions within the healthcare sector. The firm's expertise is deeply focused on corporate transactions within the global healthcare and life sciences industries, employing specialized teams with extensive knowledge in healthcare niches.
ConAlliance's Dental Segment Expertise
ConAlliance excels in the dental segment through:
1. In-depth industry understanding and market knowledge.
2. Proven track record of successful transactions in the dental sector.
3. A specialized team of experts blending investment banking with dental industry-specific expertise.
4. Extensive network within the dental market, facilitating strategic connections and tailored solutions.
5. Customized transaction solutions tailored to the unique needs of dental companies.
6. Regulatory expertise navigating complex dental sector regulations.
7. Strategic consulting beyond transaction execution, including market analysis and growth strategy development.
The transaction was led by Dipl.-Kfm. Günter Carl Hober, Managing Partner, with support from Dipl.-Kfm. Martin E. Franz, Partner, and Alexander Mast handling investor management on behalf of ConAlliance.
For more information, visit www.ConAlliance.com.